IPO watch

Microarray and genomics company AutoGenomics Inc. pulled its IPO last week. Its financial situation can't be determined, but according to its most recent S-1, the company had $4.1 million in cash at March 31, 2010, when it posted a quarterly operating loss of $4 million on product sales of $751,000.

The company markets products on its Infiniti molecular diagnostics platform, which runs 42 tests focused on women's health, cancer and personalized medicine...